Global Viral Clearance Service Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

By Method;

Viral Removal and Viral Inactivation - Chemical, Radiation and Other.

By End User;

Biopharmaceuticals, Contract Research Organizations, Academic Research Institutes and Other End-users.

By Geography;

North America, Europe, Asia Pacific, Middle East and Africa and Latin America - Report Timeline (2021 - 2031).
Report ID: Rn435107843 Published Date: January, 2025 Updated Date: February, 2025

Introduction

Global Viral Clearance Service Market (USD Million), 2021 - 2031

In the year 2024, the Global Viral Clearance Service Market was valued at USD 646.60 million. The size of this market is expected to increase to USD 1,883.28 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 16.5%.

The Global Viral Clearance Service Market is a critical component of the biopharmaceutical industry, ensuring the safety and quality of biologic drugs by effectively removing or inactivating viruses from manufacturing processes. This market encompasses a wide range of services provided by contract research organizations (CROs), contract manufacturing organizations (CMOs), and other specialized service providers.

Viral clearance services are essential in the development and production of biopharmaceuticals, including monoclonal antibodies, vaccines, and gene therapies, where the risk of viral contamination poses significant challenges to product safety and regulatory compliance. These services involve comprehensive testing and validation procedures to assess the efficacy of viral clearance methods employed during bioprocessing, such as filtration, chromatography, and inactivation steps.

With the increasing complexity of biologic drugs and stringent regulatory requirements governing their production, the demand for viral clearance services is on the rise. Factors such as the growing biopharmaceutical pipeline, expanding contract manufacturing activities, and the need for robust viral safety assurance drive market growth. Moreover, advancements in viral clearance technologies, coupled with a greater emphasis on risk mitigation and quality assurance, further propel the expansion of this market. As a result, the Global Viral Clearance Service Market plays a pivotal role in ensuring the integrity and safety of biopharmaceutical products, contributing to the overall advancement of healthcare worldwide.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Method
    2. Market Snapshot, By End User
    3. Market Snapshot, By Region
  4. Global Viral Clearance Service Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Increasing demand for biopharmaceuticals
        2. Stringent regulatory requirements for product safety
        3. Growing outsourcing trend in the pharmaceutical industry
      2. Restraints
        1. High cost associated with viral clearance services
        2. Complexity of viral clearance processes
        3. Limited expertise and infrastructure in some regions
      3. Opportunities
        1. Emerging markets with expanding biopharmaceutical sector
        2. Technological advancements in viral clearance techniques
        3. Rising adoption of single-use systems in biomanufacturing

    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Compititive Rivalry
  5. Market Segmentation
    1. Global Viral Clearance Service Market, By Method, 2021 - 2031 (USD Million)
      1. Viral Removal
      2. Viral Inactivation
        1. Chemical
        2. Radiation
        3. Other
    2. Global Viral Clearance Service Market, By End User, 2021 - 2031 (USD Million)
      1. Biopharmaceuticals
      2. Contract Research Organizations
      3. Academic Research Institutes
      4. Other End-users
    3. Global Viral Clearance Service Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. Texcell
      2. Eurofins Scientific SE
      3. Charles River Laboratories International, Inc.
      4. Merck KGaA (BioReliance)
      5. WuXi AppTec
      6. Clean Cells
      7. Vironova Biosafety
  7. Analyst Views
  8. Future Outlook of the Market